What Is MHPAEA?
The Mental Health Parity and Addiction Equity Act of 2008 is a federal law that requires group health plans and health insurance issuers offering mental health and substance use disorder (MH/SUD) benefits to provide them no more restrictively than medical/surgical benefits.
- Confirm the current federal enforcement posture before relying on the specific requirements of the 2024 rule (CMS MHPAEA page).
MHPAEA
Also known as: Mental Health Parity and Addiction Equity Act; Mental Health Parity Act; Federal Parity Law
The Mental Health Parity and Addiction Equity Act of 2008 is a federal law that requires group health plans and health insurance issuers offering mental health and substance use disorder (MH/SUD) benefits to provide them no more restrictively than medical/surgical benefits.
Definition
Enacted in 2008, MHPAEA generally provides that financial requirements and treatment limitations imposed on mental health and substance use disorder benefits cannot be more restrictive than the predominant requirements and limitations applying to substantially all medical/surgical benefits in the same classification, and it prohibits separate requirements that apply only to MH/SUD benefits. CMS states that the tests run within six classifications — inpatient in-network, inpatient out-of-network, outpatient in-network, outpatient out-of-network, emergency, and prescription drug — with sub-classification permitted for office visits separately from other outpatient services (CMS). The Affordable Care Act made MH/SUD services one of the ten essential health benefit categories, and section 203 of the Consolidated Appropriations Act, 2021 requires plans and issuers imposing non-quantitative treatment limitations on MH/SUD benefits to perform and document comparative analyses and to make them available “to the Departments or applicable State authorities, upon request”. A 2024 final rule added content requirements and response timeframes for those analyses, but its status is unsettled: on 15 May 2025 the Departments of Labor, HHS and the Treasury stated that they “will not enforce the 2024 Final Rule or otherwise pursue enforcement actions, based on a failure to comply that occurs prior to a final decision in the litigation, plus an additional 18 months”, while noting that “MHPAEA’s statutory obligations, as amended by the CAA, 2021, continue to have effect” (CMS enforcement statement). MHPAEA does not require a plan to cover MH/SUD benefits at all, and it does not apply directly to small group health plans; Medicare, Medicaid and CHIP are not group health plans, although separate Social Security Act provisions apply parity requirements to Medicaid managed care, CHIP and alternative benefit plans.
Example
A plan requires prior authorization for outpatient psychotherapy but not for a general office visit. That is a question, not a finding. The parity test compares the limitation as written and in operation against the medical/surgical benefits in the same classification — and CMS states that outpatient office visits may be sub-classified separately from other outpatient services, so the correct comparison group has to be established before anything follows from the difference. The standard is whether the processes, strategies, evidentiary standards and other factors used in applying the limitation to MH/SUD benefits are comparable to, and applied no more stringently than, those used for medical/surgical benefits in that classification. Answering that takes the plan’s own comparative analysis and the data behind it; one visible difference does not settle it.
Common Misconceptions
MHPAEA is not only about copays and visit limits — non-quantitative treatment limitations sit squarely inside it, and CMS names prior authorization and other medical management, standards for network composition, and the methodology used to set out-of-network reimbursement as examples. What follows from a disparity is less settled than it is usually made to sound. A difference has to be tested within a benefit classification, against the plan’s own processes and evidentiary standards, before it means anything; and the federal enforcement posture on the 2024 final rule is currently in flux while the Departments reconsider it. Treat a suspected parity problem as something to document and escalate, not as a concluded violation.
Practical Application
Document a suspected disparity in the terms the statute uses — which classification, which limitation, what the comparable medical/surgical benefit is, and what the plan did differently — and keep the claim-level evidence behind it. The comparative analysis itself must be made available to the Departments or the applicable state authority on request, not to a provider on demand, so the practical routes are the plan’s own appeal and external review process, the state insurance department for fully insured coverage, and the federal Departments for self-funded ERISA plans; what a participant is entitled to obtain in an ERISA claim is a question for counsel. Confirm the current federal enforcement posture before relying on the specific requirements of the 2024 rule (CMS MHPAEA page).
Related Terms
Prior Authorization
Prior authorization is the payer's process of pre-approving a planned service, procedure, medication, or admission before it is rendered, based on medical-necessity criteria; without an approved PA where required, claims typically deny under CARC 197.
Read definitionCommercial Payer
A commercial payer is a private (non-government) insurance company offering health coverage to individuals or employer groups, typically as PPO, HMO, EPO, or POS products. A fully-insured product is regulated as insurance by the state; an employer-sponsored plan that ERISA covers is also subject to the federal claims-and-appeals rule, whether that plan is fully-insured or self-funded.
Read definitionWhere This Applies on MedPrecision
Need help with billing?
If this term is showing up in your denials, EOBs, or A/R aging, we can help. Get a free billing audit and we will trace the issue to its root cause.
- No contract
- No setup fees
- Reply within 1 business day